ARQT insider buying
2 cluster buysArcutis Biotherapeutics, Inc. · Healthcare
When two or more insiders at Arcutis Biotherapeutics, Inc. buy ARQT on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in ARQT plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.
Detected clusters
- Nov 30 – Nov 30, 2024Detected Nov 30, 20243 insidersTotal bought$34.0KMarket cap$3.3B
- May 31 – May 31, 2024Detected May 31, 20242 insidersTotal bought$13.5KMarket cap$3.3B
All notable open-market buys in ARQT
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Jun 13, 2025 | Director | 2,646 | $13.08 | $34.6K | SEC ↗ |
| Jun 5, 2025 | Director | 378 | $13.41 | $5.1K | SEC ↗ |
| Jun 4, 2025 | Director | 1,890 | $13.32 | $25.2K | SEC ↗ |
| May 22, 2025 | Director | 2,520 | $13.65 | $34.4K | SEC ↗ |
| May 21, 2025 | Director | 2,520 | $13.66 | $34.4K | SEC ↗ |
| May 15, 2025 | Director | 2,520 | $13.62 | $34.3K | SEC ↗ |
| May 14, 2025 | Director | 6,300 | $13.76 | $86.7K | SEC ↗ |
| May 13, 2025 | Director | 2,374 | $13.76 | $32.7K | SEC ↗ |
| May 9, 2025 | Director | 6,300 | $13.60 | $85.7K | SEC ↗ |
| Nov 30, 2024 | Watanabe Todd Franklincluster Director, See Remarks | 2,038 | $7.11 | $14.5K | SEC ↗ |
| Nov 30, 2024 | Matsuda Masarucluster See Remarks | 1,657 | $7.11 | $11.8K | SEC ↗ |
| Nov 30, 2024 | Edwards Larry Toddcluster See Remarks | 1,093 | $7.11 | $7.8K | SEC ↗ |
| May 31, 2024 | Matsuda Masarucluster See Remarks | 4,000 | $1.69 | $6.8K | SEC ↗ |
| May 31, 2024 | Watanabe Todd Franklincluster Director, See Remarks | 4,000 | $1.69 | $6.8K | SEC ↗ |
More Healthcare stocks with insider cluster buys
ARQT insider buying — FAQ
- Are insiders buying ARQT stock?
- Yes — 4 distinct insiders have bought ARQT (Arcutis Biotherapeutics, Inc.) on the open market, including 2 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Jun 17, 2025.
- How much ARQT stock have insiders bought?
- Insiders have bought a combined $420.6K of ARQT across 14 open-market purchases, based on SEC Form 4 filings.
- What is an insider cluster buy in ARQT?
- A cluster buy is two or more distinct Arcutis Biotherapeutics, Inc. insiders — officers, directors, or 10% owners — each buying ARQT on the open market within a rolling window. ARQT has 2 detected cluster buys to date.
- Where does this ARQT insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in ARQT
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy ARQT within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding ARQT.